INDUCTION, PERSISTENCE AND PHENOTYPE OF SARS-COV-2-SPECIFIC T CELLS INDUCED BY mRNA VACCINATION

INDUCTION, PERSISTENCE AND PHENOTYPE OF SARS-COV-2-SPECIFIC T CELLS INDUCED BY mRNA VACCINATION

Ph.D

Saved in:

Bibliographic Details
Main Author:	MARTIN DANIEL CO QUI
Other Authors:	DEAN'S OFFICE (DUKE-NUS MEDICAL SCHOOL)
Format:	Theses and Dissertations
Language:	English
Published:	2024
Subjects:	adaptive immunity, t cell, immunology, covid, sars-cov-2, vaccine
Online Access:	https://scholarbank.nus.edu.sg/handle/10635/249514
Tags:	Add Tag No Tags, Be the first to tag this record!
Institution:	National University of Singapore
Language:	English

Similar Items

The Effects of Heterologous Immunization with Prime-Boost COVID-19 Vaccination against SARS-CoV-2
by: Ho, Tzu-Chuan, et al.
Published: (2022)

Higher Delta variant-specific neutralizing antibodies prevented infection in close contacts vaccinated with ancestral mRNA vaccines during the SARS-CoV-2 Delta wave
by: Goh, Yun Shan, et al.
Published: (2024)

Efficient recall of SARS-CoV-2 variant-reactive B cells and T responses in the elderly upon heterologous mRNA vaccines as boosters
by: Rouers, Angeline, et al.
Published: (2023)

Effectiveness of vaccination against SARS-CoV-2 and the need for alternative preventative approaches in immunocompromised individuals: a narrative review of systematic reviews
by: Tan, TT, et al.
Published: (2023)

Virological and serological kinetics of SARS-CoV-2 Delta variant vaccine breakthrough infections: a multicentre cohort study
by: Chia, PY, et al.
Published: (2022)

mRNA booster vaccination enhances antibody responses against SARS-CoV2 omicron variant in individuals primed with mRNA or inactivated virus vaccines
by: Zhang, Biyan, et al.
Published: (2022)

COVID-19 Vaccines Help with Herd Immunity
by: Usa Lek-Uthai
Published: (2022)

COVID-19 severity and waning immunity after up to 4 mRNA vaccine doses in 73 608 patients with cancer and 621 475 matched controls in Singapore: a nationwide cohort study
by: Tan, Wei Chong, et al.
Published: (2024)

Memory T Cell Responses Targeting the SARS Coronavirus Persist up to 11 Years Post-Infection
by: Ng, Oi Wing, et al.
Published: (2016)

Robust sars?cov?2 antibody responses in asian covid?naïve subjects 180 days after two doses of bnt162b2 mrna covid?19 vaccine
by: Lau, Chin-Shern, et al.
Published: (2022)

SARS-CoV-2 Humoral Immunity Persists Following Rituximab Therapy
by: Lu, Liangjian, et al.
Published: (2023)

EVALUATION OF ADAPTIVE IMMUNITY INDUCED BY VACCINATION AND INFECTION
by: NICHOLAS KHOO KIM HUAT
Published: (2023)

The identification and phylogenetic analysis of SARS-CoV-2 delta variants in Taiwan
by: Liu, LT, et al.
Published: (2023)

Associations of viral ribonucleic acid (RNA) shedding patterns with clinical illness and immune responses in Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) infection
by: Lee, P.H., et al.
Published: (2021)

Mechanistic insights of host cell fusion of SARS-CoV-1 and SARS-CoV-2 from atomic resolution structure and membrane dynamics
by: Chakraborty, Hirak, et al.
Published: (2021)

A phase I/II randomized, double-blinded, placebo-controlled trial of a self-amplifying Covid-19 mRNA vaccine
by: Low, Jenny G., et al.
Published: (2023)

Effectiveness of primary series and booster vaccination against SARS-CoV-2 infection and hospitalisation among adolescents aged 12–17 years in Singapore: a national cohort study
by: Chiew, CJ, et al.
Published: (2023)

Vaccines and allergic reactions: The past, the current COVID-19 pandemic, and future perspectives
by: Sampath, V, et al.
Published: (2022)

SARS-CoV-2 transmission in opposition-controlled Northwest Syria: modeling pandemic responses during political conflict
by: Marzouk, M, et al.
Published: (2022)

Clinical course, immunogenicity, and efficacy of BNT162b2 mRNA vaccination against SARS-CoV-2 infection in liver transplant recipients
by: Tan, Eunice X., et al.
Published: (2024)

Imprinting of IgA responses in previously infected individuals receiving bivalent mRNA vaccines (WT and BA.4/BA.5 or WT and BA.1)
by: Goh, Yun Shan, et al.
Published: (2024)

Reactogenicity of mRNA- and Non-mRNA-Based COVID-19 Vaccines among Lactating Mother and Child Dyads
by: Jacob-Chow, Beth, et al.
Published: (2023)

Waning of specific antibodies against Delta and Omicron variants five months after a third dose of BNT162b2 SARS-CoV-2 vaccine in elderly individuals
by: Goh, Yun Shan, et al.
Published: (2023)

Early pathogenesis profiles across SARS-CoV-2 variants in K18-hACE2 mice revealed differential triggers of lung damages
by: Aw, Zhen Qin, et al.
Published: (2023)

Analyzing COVID-19 Vaccine Responses in Transplant Recipients
by: Murali, TM, et al.
Published: (2023)

Environmental contamination of SARS-CoV-2 in a non-healthcare setting
by: Wong, Judith Chui Ching, et al.
Published: (2021)

Autoimmune sequelae after Delta or Omicron variant SARS-CoV-2 infection in a highly vaccinated cohort
by: Wee, Liang En, et al.
Published: (2024)

Exploratory analysis to identify the best antigen and the best immune biomarkers to study SARS-CoV-2 infection
by: Petruccioli, Elisa, et al.
Published: (2022)

Biochemical and functional characterization of proteins encoded by SARS-CoV subgenomic mRNA 8
by: LE TRA MY
Published: (2010)

BNT162b2 vaccination induces SARS-CoV-2 specific antibody secretion into human milk with minimal transfer of vaccine mRNA
by: Low, Jia Ming, et al.
Published: (2023)

COVID-19 infection after SARS-CoV-2 mRNA vaccination in Multiple Sclerosis, AQP4-antibody NMOSD and MOGAD patients during the Omicron subvariant BA.1/2 wave in Singapore
by: Yeo, Tianrong, et al.
Published: (2023)

Evaluation of Patients with Vaccine Allergies Prior to mRNA-Based COVID-19 Vaccination
by: Lim, Xin Rong, et al.
Published: (2023)

Rapid production of clinical-grade SARS-CoV-2 specific T cells.
by: Leung, Wing, et al.
Published: (2022)

Impact of immune enhancement on Covid-19 polyclonal hyperimmune globulin therapy and vaccine development
by: de Alwis, R., et al.
Published: (2021)

Asymptomatic COVID-19: disease tolerance with efficient anti-viral immunity against SARS-CoV-2
by: Chan, Yi-Hao, et al.
Published: (2022)

Dicoumarol is an effective post-exposure prophylactic for SARS-CoV-2 Omicron infection in human airway epithelium.
by: Peng, Yang, et al.
Published: (2023)

"In general people aren't excited about the vaccine…": Frontline perspectives on COVID-19 vaccine hesitancy across Syria
by: Alhaffar, Mervat, et al.
Published: (2023)

Linear B-cell epitopes in the spike and nucleocapsid proteins as markers of SARS-CoV-2 exposure and disease severity
by: Amrun, S.N., et al.
Published: (2021)

Age-Related Differences in Immunological Responses to SARS-CoV-2
by: LYDIA WONG SU YIN, et al.
Published: (2020)

Calculating the serial interval of SARS-CoV-2 in Lebanon using 2020 contact-tracing data
by: Haddad, N, et al.
Published: (2021)